Author

Jacopo Calabrese De Feo

Observed name: J. Calabrese De Feo

Institutions: Memorial Sloan Kettering Cancer Center, Humanitas University, IRCCS Humanitas Research Hospital

Observed institutions: Memorial Sloan Kettering Cancer Center, Humanitas University, IRCCS Humanitas Research Hospital

ORCID: 0009-0002-3043-4689

Observed ORCID: 0009-0002-3043-4689

OpenAlex ID: A5115007280

Outcomes of CD19 CAR ‐T therapy in central nervous system lymphoma: Insights from a multicentre experience

2025 · Giulio Cassanello, Efrat Luttwak, et al. · British Journal of Haematology · 12

Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma

2026 · Juan Pablo Alderuccio, Diva Baggio, et al. · Blood · 7

339 | Outcomes in an International Multicentre Study of 600 Patients With Cns Relapse of Large B Cell Lymphoma: Compartment of Relapse Is Prognostic

2025 · D. Baggio, S. Han, et al. · Hematological Oncology · 1

Prognostication and Treatment-Related Outcomes in Secondary Central Nervous System Involvement of Large B-Cell Lymphoma (SCNSL): Evidence from a Large International Cohort

2024 · Juan Pablo Alderuccio, Jahanzaib Khwaja, et al. · Blood · 1

Bendamustine in combination with gemcitabine and vinorelbine as salvage regimen for relapsed or refractory peripheral T‐cell lymphomas: A retrospective single‐centre experience

2026 · Filippo Bagnoli, Jacopo Calabrese De Feo, et al. · British Journal of Haematology

Bendamustine in Combination with Gemcitabine and Vinorelbine As Salvage Regimen for Relapsed or Refractory Peripheral T-Cell Lymphomas: A Retrospective Single Center Experience

2024 · Filippo Bagnoli, Jacopo Calabrese De Feo, et al. · Blood

Works count: 7

Citation count: 21

H-index: 2

I10-index: 1